Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500833PMID: 29999892
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 119515-38-7
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of icaridin (picaridin) during breastfeeding. However, the Centers for Disease Control and Prevention and U.S. Environmental Protection Agency consider icaridin to be safe and effective during breastfeeding when used as directed. It should be used by breastfeeding women to avoid exposure to mosquito-borne viruses.[1] Avoid application directly to the nipple and other areas where the infant might directly ingest the product.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Centers for Disease Control and Prevention. Avoid bug bites. Accessed 6-27/16. http://wwwnc
.cdc.gov /travel/page/avoid-bug-bites#repellent.
Substance Identification
Substance Name
Icaridin
CAS Registry Number
119515-38-7
Drug Class
- Breast Feeding
- Lactation
- Insect Repellents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.